Trial intelligence / Profile preview

Clinical trial of TK-98 on retinitis pigmentosa

jRCT2051180072Completed

Sponsor
Japan Agency for Medical Research and Development
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in retinitis pigmentosa (RP) comparing TK-98 with Placebo (2 arms). Primary endpoint: Change in total point score on Humphrey visual field test (10-2). Started Mar 2019; status: completed.

02

Drugs

TK-98
03

Conditions

retinitis pigmentosa (RP)

Beyond the preview

Go deeper on jRCT2051180072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2051180072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call